Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?
Article
[키워드] absence
age
association
case sery
cell counts
cerebrospinal fluid
Characteristics
clinical
Clinical characteristics
CNS
Cohort
comparable
COVID-19
CSF
demyelinating
Demyelinating disease
disease
Evidence
Follow-up
glycoprotein
indicate
initial
lesion
magnetic resonance imaging
MRI
Multiple
multiple sclerosis
Multiple sclerosis (MS)
Myelin
Myelin oligodendrocyte glycoprotein antibody-related disease (MOGAD)
Neuroinflammation
occurred
Optical coherence tomography
parameter
Patient
reported
SARS-CoV-2
SARS-CoV-2- (COVID-19) vaccination.
sclerosis
vaccination
[DOI] 10.1016/j.msard.2022.104175 PMC 바로가기
[DOI] 10.1016/j.msard.2022.104175 PMC 바로가기